Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Vet Sci ; 11: 1325198, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38605925

RESUMO

Feed additives such as monensin (MON) and virginiamycin (VM) are commonly utilized in feedlot diets to enhance rumen fermentation. Nevertheless, the precise effects of combining MON and VM during specific feedlot periods and the advantages of this combination remain unclear. This study was designed to investigate the effects of withdrawal of MON when associated with VM during the adaptation and finishing periods on ruminal metabolism, feeding behavior, and nutrient digestibility in Nellore cattle. The experimental design was a 5 × 5 Latin square, where each period lasted 28 days. Five rumen-cannulated Nellore yearling bulls were used (414,86 ± 21,71 kg of body weight), which were assigned to five treatments: (1) MON during the entire feeding period; (2) VM during the entire feeding period; (3) MON + VM during the adaptation period and only VM during the finishing period 1 and 2; (4) MON + VM during the entire feeding period; (5) MON + VM during the adaptation and finishing period 1 and only VM during the finishing period 2. For the finishing period 1, animals fed T3 had improved potential degradability of dry matter (p = 0.02). Cattle fed T3 and T5 had the highest crude protein degradability when compared to animals receiving T2 (p = 0.01). Animals fed T2 and T3 had reduced the time (p < 0.01) and area under pH 6.2 (p = 0.02). Moreover, animals fed T4 had greater population of protozoa from the genus Diplodinium (p = 0.04) when compared to those from animals fed T2, T3 and T5. For the finishing period 2, animals fed T3 had greater starch degradability when compared to animals receiving T4 and T5 (p = 0.04). Animals fed T3, T4 and T5 had increased the duration of time in which pH was below 5.6 (p = 0.03). The area under the curve for ruminal pH 5.2 and pH 5.6 was higher for the animals fed T3 (p = 0.01), and the area under pH 6.2 was higher for the animals fed T3 and T5 (p < 0.01) when compared to animals receiving T2. There is no substantial improvement on the rumen fermentation parameters by the concurrent utilization of MON and VM molecules, where the higher starch and protein degradability did not improve the rumen fermentation.

2.
Front Vet Sci ; 10: 1067434, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36761886

RESUMO

Feed additives such as monensin (MON) and virginiamycin (VM) are widely used in feedlots diets to maximize rumen fermentation. However, the knowledge about the effects of MON and VM combinations in specifics feedlot periods and the benefits of this association are still unclear. This study aimed to evaluate the effects of withdrawal of MON when associated with VM during the adaptation and finishing periods on feedlot performance of Nellore cattle. The experiment was designed as a completely randomized block replicated six times (four animals/pen) in which 120 Nellore bulls (378.4 ± 24.4 kg) were allocated in 30 pens and fed for 112 days according to the following treatments: (T1) MON during the entire feeding period; (T2) VM during the entire feeding period; (T3) MON+VM during the adaptation period and only VM during the finishing period 1 and 2; (T4) MON+VM during the entire feeding period; (T5) MON+VM during the adaptation and finishing period 1 and only VM during the finishing period 2. After 112 days on feed, no treatment effect was observed for DMI (P ≥ 0.12). However, bulls fed T5 had greater (P = 0.05) final BW and ADG when compared to T1, T2, and T4. Cattle from T3 and T5 groups presented heavier HCW (P = 0.05) than that fed T1, T2, and T4. Nellore bulls fed T1 and T5 had lower (P < 0.01) DMI variation than those receiving T2. The withdrawal of MON when associated with VM during the final third of the feedlot period improved overall final BW, ADG, and HCW when compared to bulls fed either MON or VM, but did not positively impact feedlot performance when compared to cattle that had MON withdrawn at the end of the adaptation period.

3.
Vet Parasitol ; 229: 90-92, 2016 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-27809986

RESUMO

The aim of this study was to determine the time required by different anthelmintic agents to reduce strongyle egg shedding in horses. Fifty horses were divided into five homogenous groups based on faecal egg counts (FECs). Treatment groups received either ivermectin; moxidectin; fenbendazole; piperazine; or no treatment (control group). Faecal examinations were performed 4, 8, 12, 18, 24, 36 and 48h after the anthelmintic treatment. After this period, faecal samples were taken every 24h over the next 12days and finally on alternate days (48-h intervals) for another 14days until the end of the experiment (28days post-treatment). The faecal egg count reduction (FECR) was calculated based on the post-treatment mean FECs in the controls and treated animals. Eggs were absent from the faecal examinations beginning at 72h and 4days, respectively, following treatment with moxidectin or ivermectin. Piperazine showed an FECR greater than 95% from 48h up to 9days post-treatment, with the highest FECR value recorded at 7days post-treatment (98.1%). However, the FECR was lower than 90% in the last two samplings (26 and 28days post-treatment). The febendazole group presented the lowest efficacy with FECR below 90% in all samplings. The faecal cultures showed that at the beginning of the trial, all of the groups presented with mixed infections and were predominantly composed of cyathostomins (92.8%), followed by Strongylus vulgaris (5.6%) and Triodontophorus serratus (1.6%). Only cyathostomin larvae were identified following treatment with fenbendazole or piperazine. In conclusion, horses in the present study had a segment of the cyathostomin population with resistance to fenbendazole and piperazine. The strongyle population was susceptible to macrocyclic lactones, with cessation in egg shedding three and four days after treatment with moxidectin and ivermectin, respectively.


Assuntos
Anti-Helmínticos/farmacocinética , Infecções Equinas por Strongyloidea/tratamento farmacológico , Animais , Anti-Helmínticos/uso terapêutico , Fezes/parasitologia , Feminino , Cavalos , Masculino , Contagem de Ovos de Parasitas/veterinária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...